Craig Barratt, Ph.D., Chair
Craig Barratt, Ph.D. joined the Calysta Board of Directors in 2013 and was named Board Chair in 2019. He is Senior Vice President and General Manager of the Connectivity Group at Intel Corporation. Dr. Barratt joined Intel in 2019 with the acquisition of Barefoot Networks, where he served as president and CEO. Before Barefoot, Dr. Barratt held several positions at Google, including senior vice president for Access and Energy, and CEO of Access, one of the Alphabet companies. At Google, he led various businesses and technology developments related to internet access, including Google Fiber and renewable energy.
Earlier, Dr. Barratt served as president and CEO of Atheros Communications, a Wi-Fi and networking semiconductor company, through its IPO and later acquisition by Qualcomm. Post-acquisition, Dr. Barratt was president of Qualcomm Atheros, the networking and connectivity subsidiary of Qualcomm.
Dr. Barratt is a co-inventor of a number of U.S. patents in fields including wireless communications and medical imaging, and has co-authored a book on linear controller design and open-source software.
Dr. Barratt holds a bachelor’s degree in pure mathematics and physics and a bachelor’s degree in electrical engineering, both from the University of Sydney, Australia. He also holds a master’s degree and Ph.D. in electrical engineering, both from Stanford University.
Jean-Marc Dublanc joined the Calysta Board of Directors in 2020. He is Chief Executive Officer of Adisseo Group, owned by Bluestar group, a subsidiary of ChemChina. He joined Adisseo in 2006 as Director of innovation, Marketing and Sales, and was named CEO in 2010. Mr. Dublanc began his career at Indosuez Bank and then joined the financial management of Rhone-Poulenc in 1981. He subsequently held senior operational and management positions in several subsidiaries in France and the United States. Before joining Adisseo, he was in charge of a subsidiary in the field of human nutrition. Mr. Dublanc is a graduate of the ESCP Business School in Paris, France.
David Hayes joined the Calysta Board of Directors in 2019. He is Senior Principal, BP Ventures, and brings 16 years’ experience in finance, including seven years in venture capital investing, specializing in transaction structuring. He is a Fellow of the Association of Certified Chartered Accountants (FCCA). He sits on the boards of Chromatin, Lightning Systems, Xpansiv Data Systems, and Mendel Biotechnology.
Alan Shaw, Ph.D., President, CEO and Co-Founder
Alan Shaw, Ph.D., is President, Chief Executive Officer and Co-Founder of Calysta, and a member of the Board of Directors. He joined in 2012. Dr. Shaw is a veteran biotechnology entrepreneur and chemical industry executive, with more than 25 years experience building and leading technology companies. Before joining Calysta, he was a Founder of Codexis, and served for ten years as President, Chief Executive Officer and a director. Codexis is a developer of cost-advantaged processes for production of biobased chemicals and pharmaceuticals. During his tenure, Codexis completed an IPO and expanded from a startup to a global industrial biotechnology company with operations in the United States, Europe and Asia.
In 2010, Dr. Shaw received the Ernst and Young Entrepreneur® of the Year Award in the life sciences category for Northern California. He is a member of the Board of Directors of BIO and the Governing Board of the BIO Industrial and Environmental Section. He also serves as a biotechnology advisor to the governments of the United Kingdom and Malaysia, and is a frequent speaker at leading business and industry conferences.
Prior to Codexis, Dr. Shaw held senior operating and business development positions in the United Kingdom for Chiroscience Group plc and for the chemical and biopharmaceutical units of Clariant and BTP plc from 1994-99. For the previous 15 years, he held management and scientific leadership positions for Imperial Chemical Industries plc (ICI)/Zeneca, including Business Head, Fine Chemicals and Marketing Manager, European Sales. He holds a bachelor’s degree in chemistry from Teesside University and a Ph.D. in chemistry from the University of Durham, England. He is a Fellow of the Royal Society of Chemistry and a Fellow of the Chartered Institute of Marketing.
Mike Velings joined the Calysta Board of Directors and the Advisory Board in 2015. He is the founder and the driving force behind Aqua-Spark, a global investment fund for sustainable aquaculture, combining a healthy financial profit with environmental and social impact. A lifelong entrepreneur, Mike has spent decades jumpstarting a range of successful businesses. Among other ventures, he co-founded Connexie, which has helped catalyze a professional employment industry across the Netherlands. Mike naturally combines his business background with environmental and social engagement. He understands the potential for business to create durable solutions to complex world problems. With this in mind, Mike founded A-Spark: an investment company that assists entrepreneurs across the globe in realizing their visions of a start-up with a world-changing element. Through A-Spark he has invested in a broad range of ventures over the years– both in the developed and developing world. Mike serves on several boards and is also a member of the Chairman’s Council of Conservation International and an Honorary Global Marine Fellow.